Clinical Research

Shandong Boan Biotechnology Co. Ltd.

Address
No 39 Keji Avenue, High Tech Zone

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
8
research centres
public
3
countries
person_search
20
investigators

Specializations

Bone Health and Osteoporosis

Shandong Boan Biotechnology Co. Ltd. is involved in clinical research centered on postmenopausal osteoporosis, with attention to maintaining bone mineral density and addressing bone loss in women after menopause.

  • Postmenopausal osteoporosis
  • Bone mineral density
  • Bone resorption

The sponsor’s research focus includes comparative evaluation of therapies used in osteoporosis care, with interest in clinically relevant outcomes tied to skeletal strength and bone turnover.

Endocrine and Metabolic Disorders

The sponsor’s trial activity also reflects engagement in metabolic bone disease linked to hormonal changes after menopause, a domain where estrogen deficiency contributes to reduced bone integrity.

  • Menopausal bone loss
  • Bone metabolism
  • Hormone-related skeletal decline

Its clinical interests extend to therapies that target the biological processes underlying bone remodeling and skeletal fragility.

Biologic Therapy and Comparative Clinical Evaluation

Research funded by the sponsor includes comparison of a biologic treatment with an established osteoporosis therapy, with emphasis on efficacy, safety, pharmacokinetics, and immunogenicity.

  • Biologic medicines
  • Comparative efficacy
  • Immunogenicity

This area highlights therapeutic interest in agents designed for long-term management of bone fragility and related clinical outcomes.

Bone Turnover Biomarkers

The sponsor’s research landscape includes monitoring of bone resorption markers, particularly sCTX, to assess biological effects relevant to osteoporosis treatment.

  • sCTX
  • Bone turnover markers
  • Pharmacodynamic response

These interests support clinical evaluation of therapies that influence osteoclast-mediated bone resorption and overall skeletal metabolism.

Sponsored Trials

Trial Name Country Status
Evaluation of Efficacy, Safety, Pharmacokinetics, and Immunogenicity of LY06006 Versus Denosumab in Postmenopausal Osteoporosis: A Randomized, Double-Blind StudyBulgaria BulgariaCzechia CzechiaPoland PolandNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 8 sites collaborated multiple times

This sponsor has worked with 8 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Musculoskeletal and Neural Physiological Phenomena1 trial
    28 other sponsors

Partnered Research Centres

8 centres
location_city
assignment56
Diagnostic Consultative Centre Ascendent OOD
Address
Ulitsa Bacho Kiro 47, 1202 Sofia
Learn morearrow_forward
location_city
assignment148
Futuremeds Sp. z o.o.
Address
ul. Legnicka 16, 53-673 Wroclaw
Learn morearrow_forward
location_city
assignment53
Krakowskie Centrum Medyczne Sp. z o.o.
Address
Ul. Mikolaja Kopernika 32 St, 31-501 Krakow
Learn morearrow_forward
location_city
assignment30
Medical Centre Pratia Clinic EOOD
Address
Ulitsa Doktor Siyko Siev 27, 5500 Lovech
Learn morearrow_forward
location_city
assignment30
Pratia Brno s.r.o.
Address
Hybešova 258/20, 602 00 Brno-střed
Learn morearrow_forward
location_city
assignment319
Pratia S.A.
Address
Ul. Poznanska 14, 60-185 Skorzewo
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Shandong Boan Biotechnology Co. Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.